Risk Factors for Treatment Failure with Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Anti-osteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal study of Osteoporosis in Women (GLOW), we analyzed r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Miner Res
Autors principals: Díez-Pérez, Adolfo, Adachi, Jonathan D, Adami, Silvano, Anderson, Frederick A, Boonen, Steven, Chapurlat, Roland, Compston, Juliet E, Cooper, Cyrus, Gehlbach, Stephen H, Greenspan, Susan L, Hooven, Frederick H, LaCroix, Andrea Z, Nieves, Jeri W, Netelenbos, J Coen, Pfeilschifter, Johannes, Rossini, Maurizio, Roux, Christian, Saag, Kenneth G, Silverman, Stuart, Siris, Ethel S, Wyman, Allison, Rushton-Smith, Sophie K, Watts, Nelson B
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878143/
https://ncbi.nlm.nih.gov/pubmed/23794198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars